Drug Shortage Report for OMNIPAQUE 300

Last updated on 2025-04-22 History
Report ID 255152
Drug Identification Number 02172747
Brand name OMNIPAQUE 300
Common or Proper name iohexol injection USP
Company Name GE HEALTHCARE CANADA INC
Market Status MARKETED
Active Ingredient(s) IOHEXOL
Strength(s) 647MG
Dosage form(s) SOLUTION
Route of administration RECTAL ORAL INTRA-ARTICULAR INTRAVASCULAR SUBARACHNOIDAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 50 mL
ATC code V08AB
ATC description X-RAY CONTRAST MEDIA, IODINATED
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2025-04-16
Estimated end date 2025-04-21
Actual end date 2025-04-21
Shortage status Resolved
Updated date 2025-04-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1919 MINNESOTA COURT
MISSISSAUGA, ONTARIO
CANADA L5N 0C9
Company contact information 800-387-7146 [email protected]

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2025-04-22 English Compare
v7 2025-04-21 French Compare
v6 2025-04-21 English Compare
v5 2025-04-17 French Compare
v4 2025-04-17 English Compare
v3 2025-04-17 English Compare
v2 2025-04-16 French Compare
v1 2025-04-16 English Compare

Showing 1 to 8 of 8